ZA200800992B - Benzimidazoles useful as inhibitors of protein kinases - Google Patents

Benzimidazoles useful as inhibitors of protein kinases

Info

Publication number
ZA200800992B
ZA200800992B ZA200800992A ZA200800992A ZA200800992B ZA 200800992 B ZA200800992 B ZA 200800992B ZA 200800992 A ZA200800992 A ZA 200800992A ZA 200800992 A ZA200800992 A ZA 200800992A ZA 200800992 B ZA200800992 B ZA 200800992B
Authority
ZA
South Africa
Prior art keywords
inhibitors
protein kinases
compounds
useful
benzimidazoles useful
Prior art date
Application number
ZA200800992A
Other languages
English (en)
Inventor
Everitt Simon
Hayley Binch
Mortimore Michael
Robinson Daniel
Stamos Dean
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of ZA200800992B publication Critical patent/ZA200800992B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
ZA200800992A 2005-07-26 2006-07-21 Benzimidazoles useful as inhibitors of protein kinases ZA200800992B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70239905P 2005-07-26 2005-07-26

Publications (1)

Publication Number Publication Date
ZA200800992B true ZA200800992B (en) 2009-09-30

Family

ID=37680602

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200800992A ZA200800992B (en) 2005-07-26 2006-07-21 Benzimidazoles useful as inhibitors of protein kinases

Country Status (17)

Country Link
US (1) US8076343B2 (zh)
EP (2) EP1937667B1 (zh)
JP (2) JP5255438B2 (zh)
KR (1) KR20080034483A (zh)
CN (1) CN101291927A (zh)
AT (1) ATE484501T1 (zh)
AU (1) AU2006276088A1 (zh)
CA (1) CA2616159A1 (zh)
DE (1) DE602006017574D1 (zh)
ES (1) ES2351357T3 (zh)
IL (1) IL188942A0 (zh)
NO (1) NO20080967L (zh)
NZ (1) NZ566021A (zh)
RU (1) RU2415853C2 (zh)
TW (1) TW200745088A (zh)
WO (1) WO2007015923A2 (zh)
ZA (1) ZA200800992B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7989465B2 (en) 2007-10-19 2011-08-02 Avila Therapeutics, Inc. 4,6-disubstituted pyrimidines useful as kinase inhibitors
TWI475996B (zh) 2007-10-19 2015-03-11 Celgene Avilomics Res Inc 雜芳基化合物及其用途
US9273077B2 (en) 2008-05-21 2016-03-01 Ariad Pharmaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
DK2300013T3 (en) 2008-05-21 2017-12-04 Ariad Pharma Inc PHOSPHORUS DERIVATIVES AS KINASE INHIBITORS
AU2012250517B2 (en) 2011-05-04 2016-05-19 Takeda Pharmaceutical Company Limited Compounds for inhibiting cell proliferation in EGFR-driven cancers
AU2013204563B2 (en) 2012-05-05 2016-05-19 Takeda Pharmaceutical Company Limited Compounds for inhibiting cell proliferation in EGFR-driven cancers
US9336046B2 (en) 2012-06-15 2016-05-10 International Business Machines Corporation Transaction abort processing
US9512136B2 (en) * 2012-11-26 2016-12-06 Universal Display Corporation Organic electroluminescent materials and devices
CN105209455A (zh) * 2013-03-21 2015-12-30 拜耳制药股份公司 3-杂芳基取代的吲唑
US9611283B1 (en) 2013-04-10 2017-04-04 Ariad Pharmaceuticals, Inc. Methods for inhibiting cell proliferation in ALK-driven cancers
WO2014170421A1 (en) * 2013-04-19 2014-10-23 F. Hoffmann-La Roche Ag Serine/threonine kinase inhibitors
US10793551B2 (en) 2017-10-19 2020-10-06 Effector Therapeutics Inc. Benzimidazole-indole inhibitors of Mnk1 and Mnk2
CN112552287B (zh) * 2020-12-16 2021-11-30 北京华氏精恒医药科技有限公司 一种吲哚类衍生物药物制剂及其制备方法
WO2023116888A1 (zh) * 2021-12-23 2023-06-29 杭州多域生物技术有限公司 一种五元并六元化合物、制备方法、药物组合物和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4535350B2 (ja) * 1998-11-17 2010-09-01 クミアイ化学工業株式会社 ピリミジニルベンズイミダゾール誘導体及び農園芸用殺菌剤
WO2000029404A1 (fr) * 1998-11-17 2000-05-25 Kumiai Chemical Industry Co., Ltd. Derives de pyrimidinylbenzimidazole et de triazinylbenzimidazole et bactericides agricoles/horticoles
JP2003511378A (ja) * 1999-10-07 2003-03-25 アムジエン・インコーポレーテツド トリアジン系キナーゼ阻害薬
CN1429222A (zh) * 2000-02-17 2003-07-09 安姆根有限公司 激酶抑制剂
DE60217322T2 (de) * 2001-04-27 2007-10-04 Zenyaku Kogyo K.K. Heterocyclische verbindung und antitumormittel, das diese als wirkstoff enthält
CA2486187C (en) * 2002-05-23 2013-02-19 Cytopia Pty Ltd. Kinase inhibitors
TWI335913B (en) * 2002-11-15 2011-01-11 Vertex Pharma Diaminotriazoles useful as inhibitors of protein kinases
UA80767C2 (en) * 2002-12-20 2007-10-25 Pfizer Prod Inc Pyrimidine derivatives for the treatment of abnormal cell growth
EP1704145B1 (en) * 2004-01-12 2012-06-13 YM BioSciences Australia Pty Ltd Selective kinase inhibitors

Also Published As

Publication number Publication date
CA2616159A1 (en) 2007-02-08
US8076343B2 (en) 2011-12-13
NO20080967L (no) 2008-04-22
EP2336122A1 (en) 2011-06-22
ES2351357T3 (es) 2011-02-03
TW200745088A (en) 2007-12-16
JP2013082757A (ja) 2013-05-09
EP2336122B1 (en) 2014-05-14
WO2007015923A8 (en) 2008-04-03
AU2006276088A1 (en) 2007-02-08
RU2415853C2 (ru) 2011-04-10
DE602006017574D1 (de) 2010-11-25
ATE484501T1 (de) 2010-10-15
US20070099920A1 (en) 2007-05-03
WO2007015923A3 (en) 2007-04-19
JP2009502921A (ja) 2009-01-29
KR20080034483A (ko) 2008-04-21
NZ566021A (en) 2011-03-31
WO2007015923A2 (en) 2007-02-08
IL188942A0 (en) 2008-04-13
CN101291927A (zh) 2008-10-22
JP5255438B2 (ja) 2013-08-07
RU2008106949A (ru) 2009-09-10
EP1937667B1 (en) 2010-10-13
EP1937667A2 (en) 2008-07-02

Similar Documents

Publication Publication Date Title
ZA200800992B (en) Benzimidazoles useful as inhibitors of protein kinases
SG166827A1 (en) Aminopyrimidines useful as kinase inhibitors
ZA200707342B (en) Pyrrolopyrimidines useful as inhibitors of protein kinase
TW200633980A (en) Pyridones useful as inhibitors of kinases
MX2009006690A (es) Aminopirimidinas utiles como inhibidores de proteinas cinasas.
MX2009010037A (es) Aminopirimidinas utiles como inhibidores de cinasas.
HK1113569A1 (en) Pyrazolo
MX2009008253A (es) Derivados de 2-aminopiridina utiles como inhibidores de cinasa.
MX2009006345A (es) Compuestos utiles como inhibidores de proteina cinasa.
MX2009009592A (es) Aminopiridinas utiles como inhibidores de proteinas cinasas.
HK1096673A1 (en) Compositions useful as inhibitors of protein kinases
WO2007095188A3 (en) Dihydrodiazepines useful as inhibitors of protein kinases
MX2009011811A (es) Aminopirimidinas utiles como inhibidores de cinasa.
HK1138572A1 (en) Aminopyrimidines useful as inhibitors of protein kinases
UA84930C2 (ru) Пиррольные соединения как ингибиторы протеинкиназ erk, их синтез и соответствующие промежуточные соединения
ATE542814T1 (de) Pyrazinkinaseinhibitoren
TW200604168A (en) Azaindoles useful as inhibitors of rock and other protein kinases
MX2009006700A (es) Derivados de 5-ciano-4-(pirolo)[2,3b]piridina-3-il)-pirimidinas utiles como inhibidores de proteina-cinasas.
MX2009011810A (es) Tiazoles y pirazoles utiles como inhibidores de cinasa.
MX2009012719A (es) Tiazoles y pirazoles utiles como inhibidores de cinasa.
WO2007087283A3 (en) Thiophene-carboxamides useful as inhibitors of protein kinases
WO2007139816A3 (en) Thiophene-carboxamides useful as inhibitors of protein kinases
MX2009004771A (es) Compuestos heteroaril triciclicos utiles como inhibidores de janus cinasa.
WO2007120760A3 (en) Thiophene-carboxamides useful as inhibitors of protein kinases
MX2009005231A (es) Composiciones utiles como inhibidores de proteina cinasa.